MedPath
NMPA Approval

归脾丸

国药准字Z62020704

August 9, 2024

Drug Information

归脾丸

丸剂

每丸重9g

中药

August 9, 2024

Company Information

Applicant Company

甘肃武都工业园区1号

Manufacturing Company

甘肃武都工业园区1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

归脾丸 - NMPA 批准文号 | MedPath